CAS: 1445987-21-2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | SHR0302 REF: IN-DA01NAYDCAS: 1445987-21-2 | 98% | To inquire | Tue 07 Jan 25 |
 | SHR0302 REF: TM-T9195CAS: 1445987-21-2 | 99.11% | 157.00 €~1,837.00 € | Tue 14 Jan 25 |
 | SHR0302 REF: 3D-VHC98721CAS: 1445987-21-2 | Min. 95% | To inquire | Tue 18 Feb 25 |
| SHR 0302 REF: 3D-FS182635CAS: 1445987-21-2 | Min. 95% | 189.00 €~881.00 € | Tue 04 Mar 25 |
Ref: IN-DA01NAYD
| 10mg | 199.00 € | ||
| 25mg | 336.00 € | ||
| 50mg | 538.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
SHR0302
CAS:1445987-21-2
SHR0302 (ARQ252) is a JAK inhibitor that binds JAK1 with stronger affinity than others (Selectivity …
Formula:
C18H22N8O2S
Purity:
99.11%
Color and Shape:
Solid
Molecular weight:
414.48
Ref: TM-T9195
| 1mg | 157.00 € | ||
| 5mg | 384.00 € | ||
| 10mg | 606.00 € | ||
| 25mg | 1,012.00 € | ||
| 50mg | 1,447.00 € | ||
| 100mg | 1,837.00 € | ||
| 1mL*10mM (DMSO) | 445.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
SHR0302
CAS:1445987-21-2
SHR0302 is a peptide that activates the G protein-coupled receptor. It has been shown to …
Formula:
C18H24N8O6S2
Purity:
Min. 95%
Molecular weight:
512.6 g/mol
Ref: 3D-VHC98721
| 1mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
SHR 0302
CAS:1445987-21-2
Please enquire for more information about SHR 0302 including the price, delivery time and more …
Formula:
C18H22N8O2S
Purity:
Min. 95%
Molecular weight:
414.49 g/mol
Ref: 3D-FS182635
| 1mg | 189.00 € | ||
| 2mg | 307.00 € | ||
| 5mg | 400.00 € | ||
| 10mg | 569.00 € | ||
| 25mg | 881.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
